https://storage.googleapis.com/inderes-ir-pages-prod-assets/bioretec/images/logo.svg
ENGLISH
ENGLISHFINNISH
To bioretec.com
About usInvestorsContact information
menu

About us

Investors

Bioretec as an investment

Strategy

Market

Business model

Key figures

Financial targets and dividend policy

Analysts

Listing

Releases

Subsribe to releases

Share information

Share monitor

Shareholders

Management ownership

Flagging notifications

Reports and presentations

Videos

IR calendar

Investor contacts

Disclosure policy

Corporate Governance

Annual General Meeting

Annual General Meeting 2025

Shareholders’ Nomination Board

Board of Directors

Management Team

Remuneration

Insider issues

Auditing

Risk management

Articles of association

Whistleblowing

Certified advisor

Code of Conduct

Contact information

Change language: enfi

Financial Statements Bulletin 2024

Bioretec published its Financial Statements Bulletin from 2024 on February 14, 2025. Please find result material below.

Better healing – better life

Bioretec envisions a future where orthopedic care is transformed through innovative, absorbable implants that enhance healing and reduce the need for follow-up surgeries.

Releases & news

Why Bioretec?

Superior solution for patient healing

Magnesium based absorbable implants promote bone healing and eliminate need for implant removal.

Upcoming events

Better healing — better life

Investors

As Invesment Strategy Shareholders Reports Releases

About Bioretec

Bioretec.com Activa RemeOs Newsroom Material bank

Connect

Contact us

Subscribe for company releases

© 2025 Bioretec Ltd. All rights reserved. Specifications are subject to change without notice.

Privacy Policy